Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog



Cancer vaccines: a shot in the dark?

12 May 05

The idea of developing cancer vaccines is far from a novel concept. In fact initial attempts using tumor immunotherapy to combat cancer were made in the late 19th century by the American Dr William Coley. Unfortunately, despite Dr Coley's early efforts and those of numerous others since, there is still no effective therapeutic cancer vaccine on the market.

NHS pharmaceutical messaging service

11 May 05

New on-line system for hospital pharmacies makes ordering medicines easier, quicker and, being paperless, virtually error-free.
Mike Wood

Reduce costs & increase efficiency with SMS

11 May 05

Did you know you can generate SMS messages from any software that can send an email or generate an HTTP request such as Outlook, Lotus Notes..?
Mike Wood

Addressing the crisis facing the Clinical Research Staffing market

29 Apr 05

The Healthcare Industry is currently experiencing the effects of a global shortage of qualified and experienced clinical research professionals – and this situation has evolved into the industry’s very own version of ‘Catch 22’. While employers are looking to hire candidates who are already experienced in the practice of clinical research, new Life Science graduates and others wishing to start on a career in the Healthcare Industry are unable to gain such experience without first being hired.
Kieran Engels
European Director CRAcademy

UK pharma in need of a check-up

15 Apr 05

The government's Health Select Committee has published a stinging attack on the UK pharmaceutical industry. In a report spanning 126 pages and consisting of 48 conclusions and recommendations, the committee has lambasted the way in which the UK pharmaceutical industry conducts its business and the motives by which it is driven. Datamonitor's Duncan Emerton looks at the details...

More than an interim measure

15 Apr 05

There’s a phrase being mentioned in pharmaceutical circles more and more. Sometimes with a puzzled air, other times delivered reverentially as the silver bullet that will resolve all ills: interim management.
M. Hilbert, PiR Group

Marburg outbreak raises tropical disease profile

08 Apr 05

The death toll from the Marburg virus has now risen to over 150 in Angola making it the most serious such outbreak recorded. Although the Ebola-like virus has no vaccine or curative treatment and can be rapidly fatal, news of the outbreak should serve to focus attention back on the sometimes-neglected area of tropical disease management.

Biologics hope to reach 8 million undiagnosed psoriasis sufferers

24 Mar 05

Despite almost 20 million global sufferers and comorbidities ranging from visible signs of infection to arthritis, there is no cure for psoriasis and public awareness of the disease remains low with up to 45% of sufferers undiagnosed. However, new biologic treatments and marketing campaigns are helping to bring psoriasis more into the public eye, to the benefit of all available products.

DOCS International & ICR Press Release

22 Mar 05

DOCS International in partnership with the Institute of Clinical Research (ICR) announce the launch of the CRAcademy. This exciting new intiative aims to provide relevant practical experience for Life Science graduates and others wanting to embark on a career in the Pharmaceutical Industry. Beginning on 1 April 2005, CRAcademy will organise core traineeships for starter clinical research professionals with Pharmaceutical Industry sponsors in key European countries.
Wendy Patterson

Efficacy and improved tolerability of Hypericum perforatum extract, WS 5570, compared to paroxetine in patients with moderate to severe depression

16 Mar 05

Depression is the most common mental disorder worldwide affecting around 120 million people globally. The depression market is the largest segment of the CNS market with global sales of US$15.5 billion in 2003 although this figure is dropping as generic equivalents of past blockbusters are launched. Although the depression market has matured, key areas of unmet clinical need will have to be addressed in order to drive further growth of the market. These include improvements in the safety/tolerab

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.